SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-094046
Filing Date
2010-10-19
Accepted
2010-10-19 09:07:29
Documents
6
Period of Report
2010-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K o65876e8vk.htm 8-K 19968
2 EX-1.1 o65876exv1w1.htm EX-1.1 172209
3 EX-4.1 o65876exv4w1.htm EX-4.1 62274
4 EX-5.1 o65876exv5w1.htm EX-5.1 4931
5 EX-99.1 o65876exv99w1.htm EX-99.1 8183
6 GRAPHIC o65876o6587600.gif GRAPHIC 5978
  Complete submission text file 0000950123-10-094046.txt   277617
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 101129237
SIC: 2835 In Vitro & In Vivo Diagnostic Substances